Renewed Omixon Monthly Newsletter

We are thrilled to announce that Omixon’s monthly newsletter has been renewed. We keep continuously delivering fresh news of HLA research, genetics and immunogenetics to our readers, but we are going to wrap this info package into a new format. The revamped newsletter contains more visual elements and less...

 

Read more

New Business Partnership For Guiding Microchimerism to Transplant Diagnostics with DigitalTRACE™

Omixon is pleased to announce that we have been entered a new strategic partnership of JETA Molecular BV., based in Utrecht, The Netherlands, effective as of April 2022. This partnership will combine Omixon’s expertise as an international provider of disruptive transplant diagnostics solutions with JETA Molecular latest technological solutions...

 

Read more